Scilex Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCILEX PHARMS, and when can generic versions of SCILEX PHARMS drugs launch?
SCILEX PHARMS has two approved drugs.
There are twelve US patents protecting SCILEX PHARMS drugs. There is one tentative approval on SCILEX PHARMS drugs.
There are thirty-five patent family members on SCILEX PHARMS drugs in eighteen countries.
Drugs and US Patents for Scilex Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 11,786,455 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | 9,907,751 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 11,278,623 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Scilex Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112013028802 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2012153396 | ⤷ Sign Up |
Hungary | E039266 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.